Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: TAS-108
Sponsor: SRI International
Collaborators: Taiho Pharmaceutical Co., Ltd.